John M. Wallmark

1.1k total citations
11 papers, 748 citations indexed

About

John M. Wallmark is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, John M. Wallmark has authored 11 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in John M. Wallmark's work include Cancer Immunotherapy and Biomarkers (7 papers), Colorectal Cancer Treatments and Studies (3 papers) and Immunotherapy and Immune Responses (2 papers). John M. Wallmark is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Colorectal Cancer Treatments and Studies (3 papers) and Immunotherapy and Immune Responses (2 papers). John M. Wallmark collaborates with scholars based in United States, South Korea and Canada. John M. Wallmark's co-authors include Sarina A. Piha‐Paul, Samuel Ejadi, Bhumsuk Keam, Jean‐Pierre Delord, Sanatan Saraf, Élena Elez, Roger B. Cohen, Aaron R. Hansen, Rahul Aggarwal and Juanita Lopez and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

John M. Wallmark

11 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John M. Wallmark United States	8	598	278	210	209	138	11	748
Salah-Eddin Al-Batran Germany	10	613 1.0×	441 1.6×	121 0.6×	256 1.2×	109 0.8×	30	828
Nathan Cuka United States	7	571 1.0×	255 0.9×	300 1.4×	122 0.6×	85 0.6×	10	743
Mitsuhiko Iwamoto Japan	11	258 0.4×	132 0.5×	151 0.7×	136 0.7×	47 0.3×	42	540
Soo Hee Kim South Korea	13	330 0.6×	286 1.0×	66 0.3×	115 0.6×	94 0.7×	37	652
Loreto Spencer Chile	13	239 0.4×	138 0.5×	121 0.6×	117 0.6×	73 0.5×	34	604
Takeshi Oka Japan	12	288 0.5×	252 0.9×	99 0.5×	72 0.3×	94 0.7×	17	601
Andy Karabajakian France	9	537 0.9×	246 0.9×	138 0.7×	114 0.5×	33 0.2×	19	684
Э. Э. Топузов Russia	9	376 0.6×	150 0.5×	60 0.3×	79 0.4×	123 0.9×	39	583
Joanne Wing Yan Chiu China	10	408 0.7×	132 0.5×	140 0.7×	80 0.4×	81 0.6×	22	647
JK Litton United States	5	536 0.9×	295 1.1×	198 0.9×	85 0.4×	63 0.5×	19	733

Countries citing papers authored by John M. Wallmark

Since Specialization

Citations

This map shows the geographic impact of John M. Wallmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Wallmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Wallmark more than expected).

Fields of papers citing papers by John M. Wallmark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Wallmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Wallmark. The network helps show where John M. Wallmark may publish in the future.

Co-authorship network of co-authors of John M. Wallmark

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Wallmark. A scholar is included among the top collaborators of John M. Wallmark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Wallmark. John M. Wallmark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Karuturi, Meghan, Joanne L. Blum, John M. Wallmark, et al.. (2019). Measures of functional status in adults aged ≥70 years with advanced breast cancer (ABC) receiving palbociclib (PAL) combination therapy in POLARIS. Annals of Oncology. 30. v133–v133. 4 indexed citations

Hansen, Aaron R., Christophe Massard, Patrick A. Ott, et al.. (2018). Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study. Annals of Oncology. 29(8). 1807–1813. 260 indexed citations

Cohen, Roger B., Jean‐Pierre Delord, Toshihiko Doi, et al.. (2018). Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma. American Journal of Clinical Oncology. 41(11). 1083–1088. 145 indexed citations

O’Neil, Bert H., John M. Wallmark, David Lorente, et al.. (2017). Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma. PLoS ONE. 12(12). e0189848–e0189848. 221 indexed citations

Hansen, Aaron R., Christophe Massard, Naomi B. Haas, et al.. (2016). Pembrolizumab for patients with advanced prostate adenocarcinoma: Preliminary results from the KEYNOTE-028 study. Annals of Oncology. 27. vi247–vi247. 36 indexed citations

Cohen, Roger B., Jean‐Pierre Delord, Toshihiko Doi, et al.. (2016). Preliminary results for the advanced salivary gland carcinoma cohort of the phase 1b KEYNOTE-028 study of pembrolizumab.. Journal of Clinical Oncology. 34(15_suppl). 6017–6017. 11 indexed citations

O’Neil, Bert H., John M. Wallmark, David Lorente, et al.. (2015). 502 Pembrolizumab (MK-3475) for patients (pts) with advanced colorectal carcinoma (CRC): Preliminary results from KEYNOTE-028. European Journal of Cancer. 51. S103–S103. 15 indexed citations

Herbst, Roy S., Alfonso Gúrpide, Veerle Surmont, et al.. (2014). A phase II/III randomized trial of two doses of MK-3475 versus docetaxel in previously treated subjects with non-small cell lung cancer.. Journal of Clinical Oncology. 32(15_suppl). TPS8124–TPS8124. 5 indexed citations

Lima, Caio M. Rocha, Soley Bayraktar, Jessica MacIntyre, et al.. (2012). Phase Ib Study of Drozitumab Combined With First-Line mFOLFOX6 Plus Bevacizumab in Patients with Metastatic Colorectal Cancer. Cancer Investigation. 30(10). 727–731. 33 indexed citations

10.

Wallmark, John M., et al.. (2000). Scleromyxedema: successful treatment of cutaneous and neurologic symptoms.. PubMed. 65(2). 89–92. 17 indexed citations

11.

Wallmark, John M., et al.. (1997). Tamoxifen's impact on the management of breast cancer: the oncologist's perspective.. PubMed. 11(2 Suppl 1). 49–54. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact